noel, i think you have hit the nail on the head. EXS is in play thats for sure, and any deal from here would see IVA or someone else offer us a deal for the whole company.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential